Pharmaceutical glassmaker SGD Pharma has been awarded a ‘platinum’ rating by EcoVadis, positioning it in the top 1% of all companies rated worldwide for commitment to sustainability.
EcoVadis is the internationally recognised sustainability ratings provider, evaluating over 75,000 companies globally across a range of different industries.
SGD Pharma conducted several initiatives and actions in 2020 including signing the Global Compact initiative in February 2020, demonstrating its alignment with the United Nations (UN) Sustainable Development Goals.
SGD Pharma also conducts advanced emissions calculations, which included the carbon footprint of the business in 2020.
By 2025, SGD Pharma plans to reduce 5% of its CO2 emissions per tonne of goods produced.
Other actions include the development of a corporate social responsibility (CSR) questionnaire and a code of conduct by the purchasing and CSR teams, in accordance with the UN Global Compact 10 Principles.
Further actions that SGD Pharma integrated into the business include:
- reusing internal glass offcuts to prevent waste,
- taking part in global initiatives such as green reporting to help calculate the company’s environmental impact
- and monitoring COD (chemical oxygen demand) and pH levels within their factories.
SGD also achieved a B rating from CDP, which is based on its approach to climate change.
This score is higher than both the Europe regional average and the manufacturing sector’s average (of grade C), placing SGD Pharma in the ‘Management’ band of companies taking coordinated action on climate issues.